Elevance Health Plunges 6.25% on Wells Fargo Price Target Cut

On July 17, 2025, Elevance Health's stock experienced a significant drop of 6.25% in pre-market trading, reflecting a notable decline in investor sentiment.

Wells Fargo recently reduced its price target for Elevance Health from $478 to $400, citing concerns over margin uncertainty in key segments. This adjustment, while maintaining an 'Overweight' rating, has contributed to the negative market sentiment surrounding the stock.

Analysts have noted that the price target reduction is due to the company's performance in critical areas, which has raised questions about its future profitability. This has led to a new 52-week low for Elevance Health, further impacting investor confidence.